Connect with us

Technology

ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA

Published

on

CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform. This collaboration leverages NVIDIA Inference  microservices (NIM), including the recently published Llama 3 NIM, along with NVIDIA CUDA-X microservices, and the NVIDIA NeMo platform.

Over the past two years, ConcertAI has assembled the deepest and largest multi-modal oncology data repository in the industry, representing more than 8 million patients. This effort was significantly accelerated in December 2023, when the American Society of Clinical Oncology (ASCO) CancerLinQ program became a ConcertAI initiative under a long-term cooperation agreement with ASCO. In collaboration with molecular diagnostic partners and its radiological imaging business, TeraRecon, ConcertAI has established a research capability that spans genomic, transcriptomic, digital pathology, digital radiology, clinical, and social determinants of health data. This comprehensive data set covers all 50 states, offering the broadest representativeness and generalizability of any clinical data source, and forms the foundation for a range of next-generation AI models and AI-powered services. In January, the company announced its CARA AI platform, which underpins a new class of AI SaaS solutions powered by the company’s multi-modal data solutions and supports healthcare providers, research sites, and life science companies. 

As part of the collaboration, ConcertAI’s efforts to drive leading intelligence and insight in oncology research and treatment will be supported by NVIDIA’s AI expertise and infrastructure. This includes incorporating the Meta Llama 3 NIM, announced at Computex today, to drive key LLM workloads inside ConcertAI’s suite of solutions. The focus of ConcertAI’s work with NVIDIA will be on large-scale clinical data processing, multi-agent models, clinical foundation models, and related solutions that enable domain-specific AI and broad application generative AI to interoperate with unprecedented precision.

Key initiatives under this collaboration include:

High-performance AI models for clinical development solutions: This initiative will leverage NVIDIA NIMs to provide scalable, high-performance AI model deployment with low latency, enhancing flexibility, interoperability, and cost efficiency within the ConcertAI CARA AI platform. The integration will support clinical trial patient matching, protocol automation, and research site co-pilots with real-time analytics and model management for large-scale AI applications.Large-scale processing of multi-modal data: This initiative will harness NVIDIA CUDA-X microservices to accelerate ConcertAI’s large-scale data processing pipelines, significantly enhancing the largest curated oncology data set globally. By leveraging CUDA-X’s advanced computing capabilities, ConcertAI will achieve faster data processing speeds and efficiency, enabling more effective management of its vast oncology data.Development of precision oncology and medical large language models (LLMs): These foundation models, trained on ConcertAI’s industry-leading multi-modal data, will support advanced translational simulations to guide novel, first-in-human studies, clinical trial simulations and design optimizations, clinical decision augmentation support for clinical pathways, and identification of beneficial diagnostic and treatment approaches.

“Life sciences research and precision medicine both involve complex decisions based on many types of data and time points,” said Jeff Elton, PhD, CEO of ConcertAI. “For any single patient, we may have billions of unique data points, and we may be looking across millions of records, making this a domain where AI can enable insights not possible with prior technologies or methodologies. We are thrilled to work with NVIDIA to push the boundaries of what AI can achieve in oncology translational research, clinical development, and care. Our collaboration will bring unprecedented precision and new levels of efficiency to our customers’ development of new medicines, helping accelerate the improvement of outcomes for patients with the greatest unmet medical needs.”

“AI offers incredible potential to transform how medicines are designed and developed, and bringing generative AI tools to improve clinical trials is a groundbreaking and necessary step,” said Kimberly Powell, VP of Healthcare at NVIDIA. “Integrating NVIDIA’s NIM’s into ConcertAI’s SaaS and extensive multi-modal data platform will revolutionize clinical trial design and outcome prediction.”

This collaboration underscores ConcertAI’s commitment to harnessing the power of AI to drive innovation in healthcare and improve patient outcomes worldwide. Initial benefits from the collaboration will be accessible in the CARA AI cloud and solutions in Q3 of 2024.

About ConcertAI

ConcertAI is the leader in Predictive and Generative AI SaaS and Real-world Data research solutions and healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARA™ AI technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2000 health care providers, and medical societies.  CancerLinQ® is an Initiative of ConcertAI, providing oncology providers ASCO aligned automated QOPI quality solutions and SmartLinQ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, Tokyo. For more information, visit us at https://www.concertai.com

Media Contact: Megan Duero, megan@galestrategies.com 

View original content:https://www.prnewswire.com/news-releases/concertai-to-advance-translational-and-clinical-development-solutions-in-collaboration-with-nvidia-302161245.html

SOURCE ConcertAI

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BASX Hosts Ribbon-Cutting Ceremony for New State-of-the-Art Weld Shop

Published

on

By

REDMOND, Ore., Sept. 19, 2024 /PRNewswire/ — BASX (“BASX” or the “Company”), a leader in the manufacturing of high-efficiency data center cooling solutions, cleanroom systems, and custom HVAC systems, is proud to announce the official ribbon-cutting ceremony for its newly completed 36,000-square-foot weld shop. The Redmond Chamber of Commerce performed the ribbon cutting on September 18th, 2024, at BASX headquarters.

The weld shop will create significant job opportunities in the Central Oregon region, with the capacity to fill an additional 30 welding positions. Positions range from entry-level to experienced roles, with professional opportunities in various growing departments within the Company.

“This new facility is a major investment not just in our company, but in the future of Central Oregon,” said Dave Benson, AAON VP and BASX President. “We can now deliver even higher levels of quality and efficiency while providing more job opportunities for the community. We’re proud to support local manufacturing growth and look forward to seeing the impact this expansion will have on both BASX and the region.”

The new shop marks a major expansion in the Company’s production capabilities, introducing state-of-the-art welding technology within a climate-controlled environment. Equipped with advanced air filtration systems, including an AAON make-up air unit and multiple air scrubbers, the shop ensures exceptional air quality for its workers. The space also features two 5-ton overhead cranes and six ½-ton cantilever jib cranes, allowing for efficient movement of materials across the facility.

A key highlight of the facility is its cutting-edge tube laser, capable of precision cutting and profiling round and square tubes, as well as C-channel and I-beam profiles up to 27 feet in length. Additionally, a 75-foot-long dual-zone robotic welding cell is scheduled to be installed and operational in early 2025, enabling the welding of large subassemblies up to 10 tons.

The shop’s innovative capabilities will support the Company’s growth and solidify its position for ongoing expansion. In addition to the 30 new welding jobs, BASX is actively hiring across various departments to support its continued success. To learn more about available positions and apply, visit the BASX careers page at www.basxsolutions.com/careers.

About BASX
Founded in 2014 in Central Oregon, BASX is an industry leader in the manufacturing of high-efficiency data center cooling solutions, cleanroom systems, custom HVAC systems, and modular solutions. Acquired by AAON in 2021, BASX continues to focus on quality, innovation, and state-of-the-art technology. The Company is proud to display the Made-in-America emblem on all its products. For more information, please visit www.basx.com.

Contact Information
Christina Lattanzio
Marketing Manager
(918) 508-9272
Email: Marketing@basx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/basx-hosts-ribbon-cutting-ceremony-for-new-state-of-the-art-weld-shop-302253745.html

SOURCE AAON

Continue Reading

Technology

NASA Sets Coverage for Astronaut Tracy C. Dyson, Crewmates Return

Published

on

By

WASHINGTON, Sept. 19, 2024 /PRNewswire/ — NASA astronaut Tracy C. Dyson, accompanied by Roscosmos cosmonauts Nikolai Chub and Oleg Kononenko, will depart from the International Space Station aboard the Soyuz MS-25 spacecraft, and return to Earth.

Dyson, Chub, and Kononenko will undock from the orbiting laboratory’s Prichal module at 4:37 a.m. EDT Monday, Sept. 23, heading for a parachute-assisted landing at 8 a.m. (5 p.m. Kazakhstan time) on the steppe of Kazakhstan, southeast of the town of Dzhezkazgan.

NASA’s live coverage of return and related activities will stream on NASA+ and the agency’s website. Learn how to stream NASA content through a variety of platforms, including social media.

A change of command ceremony also will stream on NASA platforms at 10:15 a.m. Sunday, Sept. 22. Kononenko will hand over station command to NASA astronaut Suni Williams for Expedition 72, which begins at the time of undocking.

Spanning 184 days in space, Dyson’s mission includes covering 2,944 orbits of the Earth and a journey of 78 million miles. The Soyuz MS-25 spacecraft launched March 23, and arrived at the station March 25, with Dyson, Roscosmos cosmonaut Oleg Novitskiy, and spaceflight participant Marina Vasilevskaya of Belarus. Novitskiy and Vasilevskaya were aboard the station for 12 days before returning home with NASA astronaut Loral O’Hara on April 6.

Kononenko and Chub, who launched with O’Hara to the station on the Soyuz MS-24 spacecraft last September, will return after 374 days in space and a trip of 158.6 million miles, spanning 5,984 orbits.

Dyson spent her fourth spaceflight aboard the station as an Expedition 70 and 71 flight engineer, and departs with Kononenko, completing his fifth flight into space and accruing an all-time record 1,111 days in orbit, and Chub, who completed his first spaceflight.

After returning to Earth, the three crew members will fly on a helicopter from the landing site to the recovery staging city of Karaganda, Kazakhstan. Dyson will board a NASA plane and return to Houston, while Kononenko and Chub will depart for a training base in Star City, Russia.

NASA’s coverage is as follows (all times Eastern and subject to change based on real-time operations):

Sunday, Sept. 22
10:15 a.m. – Expedition 71/72 change of command ceremony begins on NASA+ and the agency’s website.

Monday, Sept. 23
12:45 a.m. – Hatch closing coverage begins on NASA+ and the agency’s website.

1:05 a.m. – Hatch closing

4 a.m. – Undocking coverage begins on NASA+ and the agency’s website.

4:37 a.m. – Undocking

6:45 a.m. – Coverage begins for deorbit burn, entry, and landing on NASA+ and the agency’s website.

7:05 a.m. – Deorbit burn

8 a.m. – Landing

For more than two decades, people have lived and worked continuously aboard the International Space Station, advancing scientific knowledge, and making research breakthroughs that are not possible on Earth. The station is a critical testbed for NASA to understand and overcome the challenges of long-duration spaceflight and to expand commercial opportunities in low Earth orbit. As commercial companies focus on providing human space transportation services and destinations as part of a robust low Earth orbit economy, NASA is focusing more resources on deep space missions to the Moon as part of Artemis in preparation for future human missions to Mars.

Learn more about International Space Station research and operations at:

https://www.nasa.gov/station

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-sets-coverage-for-astronaut-tracy-c-dyson-crewmates-return-302253747.html

SOURCE NASA

Continue Reading

Technology

Global claims guidance leader EvolutionIQ joins as CALI’s inaugural Life Partner

Published

on

By

NEW YORK, Sept. 20, 2024 /PRNewswire/ — US-based EvolutionIQ, a global leader in claims guidance technology, has signed on as the Council of Australian Life Insurers (CALI)’s first Life Partner as part of its corporate partner program.

The CALI Partner Program is designed to foster collaboration and create a connected ecosystem of industry experts.

CALI Life Partners share the industry’s mission to make life insurance accessible, understandable and trusted. They are companies that support Australian life insurers to help Australians and their families have peace of mind about their future so they can live in the most healthy, confident and secure way.

“We are pleased to welcome EvolutionIQ as CALI’s inaugural Life Partner. The CALI Partner Program plays an important role in connecting our members to the latest innovators, like EvolutionIQ, that can move their businesses forward,” said CALI CEO Christine Cupitt.

“We want to work closely with each of our partners to strengthen and support the life insurance industry to deliver better customer experiences for millions of Australians on their best and worst days.”

Headquartered in New York, EvolutionIQ has expanded significantly since 2019. Its clients include major insurance carriers such as Sun Life, Reliance Matrix and Principal Financial. Their AI-powered software makes insurance claims processes more personalised, fair and cost-effective so that more people can recover faster and return to work.

“We are committed to supporting the Australian life insurance ecosystem and being a CALI Life Partner enables us to specialise our products to meet the dynamic needs of the Australian markets,” said EvolutionIQ’s Co-CEO, Mike Saltzman.

“Our partnership with CALI means we can contribute to and shape customer experiences in Australia, and ultimately help more people return to health and a livelihood sooner.”

About EvolutionIQ
EvolutionIQ pioneered Claims Guidance in 2019. Its explainable AI guides insurance claims professionals to their highest potential impact claims, improving the claimant experience and delivering better claim outcomes to claimants, carriers and their customers. EvolutionIQ serves the group disability, individual disability and workers’ compensation markets worldwide. EvolutionIQ’s AI native products have been adopted by 70% of the top 15 U.S. disability carriers and a growing list of workers’ compensation carriers. The New York-based company employs 185 staff across the United States, Europe and Australia. For more information, visit evolutioniq.com and follow the company on LinkedIn.

About CALI
We support Australians to make informed choices about their future and help them live in a healthy, confident and secure way over their lifetime.

Our members’ products and services give people peace of mind when making important decisions and provide a financial safety net during life’s biggest challenges.

We advocate for national policy settings that expand Australians’ access to the life insurance protection that suits them when they need it most.

CALI represents all life insurers and reinsurers in Australia. The Australian life insurance industry is today a $26.4billion industry, employing thousands of Australians and paying billions of dollars of benefits each year.

To view CALI’s corporate partners visit www.cali.org.au/about-us/#our-partners

For more information, visit www.cali.org.au

Media Contact
Jason Kapler
Vice President of Marketing
EvolutionIQ
(917) 740-5608
Press@evolutioniq.com

Logo – https://mma.prnewswire.com/media/1723642/EvolutionIQ_Logo.jpg
Logo – https://mma.prnewswire.com/media/2509100/CALI_logo.jpg

View original content:https://www.prnewswire.com/apac/news-releases/global-claims-guidance-leader-evolutioniq-joins-as-calis-inaugural-life-partner-302253427.html

SOURCE EvolutionIQ

Continue Reading

Trending